acut
equin
coliti
diseas
associ
signific
morbid
mortal
individu
hors
potenti
impact
herd
given
enorm
size
function
equin
larg
intestin
acut
coliti
quickli
becom
acut
coliti
respons
admiss
equin
veterinari
hospit
aetiolog
undetermin
usual
case
mortal
cumul
impact
profound
rel
low
number
present
individu
set
suggest
scale
problem
usual
recognis
equin
research
collabor
improv
understand
need
develop
better
standardis
term
coliti
eg
mild
moder
sever
acut
chronic
individu
studi
combin
obtain
statist
valid
acut
coliti
typic
defin
clinic
presenc
diarrhoea
usual
occur
hors
small
bowel
inflamm
potenti
sign
includ
fever
neutropenia
inappet
ultrasonograph
evid
increas
colon
wall
thick
increas
fluid
within
caecum
andor
colon
case
fatal
increas
presenc
toxic
neutrophil
peripher
blood
hors
present
two
sign
system
inflammatori
respons
syndrom
sir
admiss
high
fatal
rate
develop
coliti
score
system
would
includ
agent
determin
would
enhanc
possibl
collabor
research
mani
aspect
acut
coliti
coliti
broad
term
use
describ
common
symptomatolog
due
multipl
aetiolog
clostridioid
difficil
neorickettsia
risticii
salmonella
spp
agent
infecti
equin
acut
coliti
import
geograph
epidemiolog
differ
relat
caus
exampl
retrospect
data
present
denmark
reveal
cyathostomiasi
common
caus
salmonella
spp
never
detect
contrast
australia
c
difficil
salmonella
spp
infect
common
although
case
aetiolog
determin
noninfecti
caus
coliti
eg
acorn
nonsteroid
drug
intox
may
occur
clostridioid
difficil
agre
diagnos
caus
equin
acut
coliti
might
bias
limit
current
diagnost
approach
import
direct
toxin
rather
gene
detect
faec
colon
content
recognis
import
diagnosi
sinc
polymeras
chain
reaction
pcr
gene
detect
may
pick
carrier
state
north
america
increas
number
case
potomac
hors
fever
phf
note
recent
year
identif
novel
strain
n
risticii
like
repres
novel
neorickettsia
speci
identifi
current
test
diagnosi
salmonellosi
problemat
set
salmonella
spp
common
veterinari
hospit
may
skew
aetiolog
diagnos
contribut
coliti
diagnosi
poor
current
understand
c
perfringen
like
overdiagnos
adult
hors
coliti
scientif
evid
need
support
role
c
perfringen
adult
hors
coliti
includ
role
type
c
newli
describ
strain
base
direct
toxin
rather
gene
test
earlier
data
suggest
import
c
perfringen
enterotoxin
cpe
acut
coliti
support
recent
studi
data
present
suggest
c
perfringen
best
rel
unimport
acut
equin
coliti
first
time
clostridium
sordellii
suggest
presumpt
caus
acut
fatal
coliti
adult
hors
provid
support
suggest
yet
unknown
caus
equin
coliti
experiment
infect
studi
may
requir
confirm
role
viral
caus
acut
coliti
uncommon
although
outbreak
equin
coronaviru
may
caus
diarrhoea
mimic
salmonellosi
consider
interest
dna
sequenc
ng
technolog
help
better
understand
equin
intestin
microbiom
microbiolog
consequ
case
coliti
extens
inform
characteris
equin
faecal
microbiom
relat
age
antibiot
use
colic
deworm
diet
exercis
immun
pregnanc
ship
studi
need
confirm
trend
understand
variabl
among
differ
healthi
sick
state
recent
increas
interest
human
microbiom
research
result
increas
interest
role
equin
microbiom
health
diseas
one
workshop
particip
report
higher
propens
age
geriatr
hors
develop
coliti
univers
occur
need
known
relat
microbiota
anatom
physiolog
compartmentalis
larg
intestin
includ
may
impact
develop
coliti
typic
mark
chang
reduct
divers
equin
faecal
microbiom
coliti
microbiom
chang
equin
coliti
caus
effect
coliti
result
dysbiosi
need
understand
whether
dysbiosi
use
concept
ration
predispos
hors
coliti
chang
larg
bowel
microbiom
specif
caus
diarrhoea
characterist
chang
faecal
microbiom
chang
similar
case
baselin
trend
faecal
microbiom
hors
affect
c
difficil
neorickettsia
spp
salmonella
spp
suscept
microbiom
hors
individu
microbiom
characteris
ever
use
identifi
hors
workshop
attende
agre
systemat
quest
new
aetiolog
agent
understand
pathogenesi
coliti
prioriti
multin
interdisciplinari
research
programm
microbiom
analysi
base
rrna
analysi
current
oper
inde
somewhat
crude
level
ng
studi
may
first
step
identifi
individu
pathogen
recent
ongo
remark
improv
method
isol
major
intestin
bacteria
integr
metagenom
analysi
identifi
novel
agent
isol
reveal
greater
intestin
microb
divers
deep
sequenc
approach
power
techniqu
could
appli
equin
coliti
hunt
new
previous
ignor
pathogen
workshop
agre
need
creat
biobank
coliti
sampl
multipl
locat
part
search
new
agent
therapeut
microbiota
manipul
faecal
microbiota
transplant
fmt
use
great
success
human
anim
speci
although
basi
efficaci
still
fulli
agre
fmt
highli
effect
treat
chronic
c
difficil
infect
human
pilot
studi
undertaken
hors
diarrhoea
present
well
control
clinic
studi
necessari
intervent
recommend
therapeut
option
hors
coliti
know
microbiom
consider
affect
case
coliti
research
need
fmt
coliti
super
donor
hors
best
protocol
perform
fmt
screen
donor
happen
patient
microbiom
transfaun
valu
last
despit
signific
improv
past
year
aetiolog
approxim
case
coliti
worldwid
remain
undetermin
even
extens
diagnost
work
includ
examin
histopatholog
bacteri
cultur
pcr
toxicolog
etc
aetiolog
diagnosi
may
avoid
sinc
expens
also
data
eg
c
perfringen
cpa
gene
detect
unknown
confus
signific
addit
treatment
current
depend
larg
symptomat
support
approach
base
clinicopatholog
find
rather
proven
target
intervent
phf
except
may
judg
better
spend
money
treatment
high
cost
sometim
uncertain
neg
diagnosi
nevertheless
absenc
reliabl
rapid
diagnosi
import
consequ
limit
understand
coliti
specif
prevent
treatment
clear
consensu
among
workshop
particip
need
standardis
test
protocol
known
agent
improv
abil
compar
differ
studi
multiplex
pcr
known
pathogen
adult
coliti
panel
commonli
use
diagnosi
equin
enterocol
one
studi
identifi
quarter
posit
sampl
known
pathogen
complic
identif
second
pathogen
quarter
case
even
third
pathogen
small
proport
like
genuin
especi
underli
common
predispos
factor
antimicrobi
drug
use
howev
determin
whether
identifi
faec
actual
agent
diseas
rather
incident
find
challeng
especi
highli
sensit
diagnost
note
earlier
clearli
agent
assess
panel
well
gene
cpa
toxin
gene
panel
sinc
c
perfringen
quit
frequent
healthi
adult
hors
aetiolog
diagnosi
c
difficil
infect
improv
dramat
introduct
elisa
detect
preform
clostridi
toxin
colon
content
faec
better
approach
pick
carrier
diagnost
pcr
panel
diagnost
approach
chang
light
chang
understand
effort
made
identifi
sensit
specif
standardis
salmonella
spp
cultur
necessari
assist
compar
data
variou
geograph
locat
studi
exampl
amount
faec
sampl
salmonella
spp
infect
determin
rel
sensit
test
miss
case
due
sampl
practic
test
salmonella
spp
also
complic
lack
clear
quantit
analys
diagnosi
persist
shed
healthi
hors
diagnosi
challeng
due
multipl
aetiolog
involv
decid
ideal
test
one
must
know
preval
healthi
hors
sensit
specif
test
clinic
valu
posit
result
although
seem
straightforward
clinic
consequ
ignor
literatur
practition
need
decid
pretest
probabl
posit
result
whether
posit
result
alter
cours
treatment
pretest
probabl
low
may
best
appli
financi
resourc
toward
treatment
understand
appli
possibl
test
may
best
rout
diagnosi
treatment
acut
coliti
sinc
may
still
import
know
test
import
question
therefor
practition
may
simpl
provid
owner
peac
mind
detect
infect
potenti
zoonot
agent
common
caus
coliti
produc
larg
bowel
lesion
mani
time
morpholog
indistinguish
nevertheless
understand
improv
standardis
diagnost
protocol
necessari
hors
die
subject
euthanasia
coliti
well
clinic
ill
anim
current
lack
standard
protocol
necropsi
hors
die
coliti
imped
progress
standard
care
hors
acut
coliti
well
defin
prospect
randomis
control
clinic
trial
rct
particular
although
flunixin
meglumin
polymyxin
b
lidocain
smectit
biospongetm
wide
use
treatment
coliti
valu
well
establish
still
use
nonsteroid
drug
contribut
coliti
use
antimicrobi
without
evid
sepsi
also
controversi
could
affect
commens
bacteria
remain
gut
worsen
intestin
dysbiosi
morphin
use
replac
expens
lidocain
pain
control
meloxicam
less
harm
flunixin
meglumin
sinc
seem
reduc
fluid
flux
compar
flunixin
vitro
sinc
flunixin
delay
tight
junction
closur
therapeut
use
hors
acut
coliti
base
studi
studi
either
retrospect
use
small
sampl
size
regardless
caus
howev
treatment
coliti
aim
improv
cardiovascular
perfus
provid
oncot
support
address
endotoxaemia
restor
gut
microbiom
prevent
lamin
prevent
lamin
ice
feet
cryotherapi
import
advanc
address
common
complic
coliti
workshop
one
studi
present
found
administr
plasma
hors
coliti
improv
surviv
retrospect
studi
wherea
anoth
found
hors
administ
plasma
like
surviv
treat
hetastarch
work
need
area
propos
multicentr
rct
valu
hyperimmun
plasma
announc
workshop
collabor
ventur
particip
hope
would
pilot
becom
collabor
standard
approach
assembl
number
case
need
treatment
studi
speed
progress
prevent
depend
improv
understand
agent
coliti
improv
understand
larg
intestin
microbiom
manipul
well
risk
efficaci
immunis
establish
pathogen
workshop
reveal
much
need
done
understand
address
acut
coliti
adult
hors
mani
question
caus
diagnost
treatment
approach
given
rel
low
case
load
present
individu
equin
veterinari
set
best
answer
prospect
rct
studi
collabor
centr
acut
coliti
last
frontier
equin
medicin
need
systemat
studi
expand
understand
equin
intestin
microbiom
health
diseas
improv
cultur
techniqu
combin
metagenom
identifi
known
well
new
pathogen
requir
excel
collabor
scienc
well
consider
research
fund
critic
prioriti
consensu
consist
guidelin
infecti
agent
test
common
score
system
coliti
sever
allow
collabor
prospect
comparison
valu
exist
novel
treatment
studi
differ
set
provid
statist
power
make
use
conclus
reader
interest
join
intern
equin
coliti
research
group
contact
larroyo
uoguelphca
grate
dorothi
russel
havemey
foundat
presid
gene
pranzo
support
workshop
second
havemey
workshop
equin
coliti
organis
